|
ZNF514 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.977800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.357330E-03 |
| Normal-vs-Stage2 |
8.01500000000566E-05 |
| Normal-vs-Stage3 |
7.8925000000063E-05 |
| Normal-vs-Stage4 |
4.064200E-01 |
| Stage1-vs-Stage2 |
8.421900E-02 |
| Stage1-vs-Stage3 |
1.493760E-01 |
| Stage1-vs-Stage4 |
1.861810E-01 |
| Stage2-vs-Stage3 |
5.158800E-01 |
| Stage2-vs-Stage4 |
2.096300E-02 |
| Stage3-vs-Stage4 |
4.711800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.875100E-03 |
| Normal-vs-AfricanAmerican |
1.466350E-02 |
| Normal-vs-Asian |
1.965410E-01 |
| Caucasian-vs-AfricanAmerican |
6.068400E-01 |
| Caucasian-vs-Asian |
1.621220E-01 |
| AfricanAmerican-vs-Asian |
1.298550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.370200E-02 |
| Normal-vs-Female |
1.982820E-04 |
| Male-vs-Female |
4.246200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.476540E-03 |
| Normal-vs-Age(41-60Yrs) |
5.848700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.291590E-02 |
| Normal-vs-Age(81-100Yrs) |
4.27999999996764E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.063400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.076800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.754200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.084190E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.912190E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.766500E-02 |
| Classical-VS-Follicular |
2.019300E-03 |
| Classical-VS-Other |
5.412400E-01 |
| Classical-VS-Normal |
1.074420E-02 |
| Tall-VS-Follicular |
6.269200E-01 |
| Tall-VS-Other |
1.255240E-01 |
| Tall-VS-Normal |
8.448800E-04 |
| Follicular-VS-Other |
1.072360E-01 |
| Follicular-VS-Normal |
2.06779999999407E-05 |
| Other-VS-Normal |
6.719400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.18070000000248E-05 |
| Normal-vs-N1 |
5.865000E-01 |
| N0-vs-N1 |
2.356400E-02 |
|
|
